ZyVersa Therapeutics | DEFA14A: Others
ZyVersa Therapeutics | 10-K: Annual report
ZyVersa Therapeutics | DEF 14A: Definitive information statements
ZyVersa Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
ZyVersa Therapeutics | 8-K: Current report
ZyVersa Therapeutics | 8-K: Current report
ZyVersa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ionic Ventures, LLC(4.0%),Ionic Management, LLC(4.0%), etc.
ZyVersa Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
ZyVersa Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Anson Funds Management LP(9.8%),Anson Management GP LLC(9.8%), etc.
ZyVersa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-L1 Capital Global Opportunities Master Fund Ltd.(0%)
ZyVersa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-INCON Co., Ltd.(3.44%)
ZyVersa Therapeutics | 8-K: Current report
ZyVersa Therapeutics | 8-K: Current report
ZyVersa Therapeutics | 424B4: Prospectus
ZyVersa Therapeutics | EFFECT: Others
ZyVersa Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
ZyVersa Therapeutics | CORRESP: CORRESP
ZyVersa Therapeutics | CORRESP: CORRESP
ZyVersa Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
ZyVersa Therapeutics | 8-K: Current report
No Data